SCPXD Projected Dividend Yield
Scorpius Holdings Inc ( OTCBB : SCPXD )NightHawk Biosciences is a biopharmaceutical company focusing on the development, manufacturing, and commercialization of medical countermeasures for infectious disease. Co.'s subsidiary, Elusys Therapeutics, Inc., develops ANTHIM® (obiltoxaximab), a monoclonal antibody that is used in adults and pediatric patients for the treatment of inhalational anthrax in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not appropriate or available. Co.'s subsidiary, Scorpius Biomanufacturing, Inc., provides process development and biomanufacturing services to support its biotherapeutics and discovery pipeline. 21 YEAR PERFORMANCE RESULTS |
SCPXD Dividend History Detail SCPXD Dividend News SCPXD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |